STOCK TITAN

Cyclacel Pharmaceuticals to Release Third Quarter 2023 Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Cyclacel Pharmaceuticals, Inc. will release its third quarter 2023 financial results on November 13, 2023, and host a conference call and live webcast the same day.
Positive
  • None.
Negative
  • None.

BERKELEY HEIGHTS, N.J., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce third quarter 2023 financial results on Monday, November 13, 2023. The Company will host a conference call and live webcast at 4:30 p.m. Eastern Time on the same day.

Conference call information:

Call: (800) 245-3047 / international call: (203) 518-9765

Archive: (800) 688-7036 / international archive: (402) 220-1346 

Code for live and archived conference call is CYCCQ323. Webcast link

For the live and archived webcast, please visit the Corporate Presentations page on the Cyclacel website at www.cyclacel.com. The webcast will be archived for 90 days and the audio replay for 7 days. 

About Cyclacel Pharmaceuticals, Inc.

Cyclacel is a clinical-stage, biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation, epigenetics and mitosis biology. The transcriptional regulation program is evaluating fadraciclib, a CDK2/9 inhibitor, and the epigenetic/anti-mitotic program plogosertib, a PLK1 inhibitor, in patients with both solid tumors and hematological malignancies. Cyclacel’s strategy is to build a diversified biopharmaceutical business based on a pipeline of novel drug candidates addressing oncology and hematology indications. For additional information, please visit www.cyclacel.com.

Contacts

Company:Paul McBarron, (908) 517-7330, pmcbarron@cyclacel.com
Investor Relations:Grace Kim, IR@cyclacel.com
  

© Copyright 2023 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The Cyclacel logo and Cyclacel® are trademarks of Cyclacel Pharmaceuticals, Inc.


FAQ

When will Cyclacel Pharmaceuticals, Inc. announce its third quarter 2023 financial results?

Cyclacel Pharmaceuticals, Inc. will announce its third quarter 2023 financial results on November 13, 2023.

What time will the conference call and live webcast be held?

The conference call and live webcast will be held at 4:30 p.m. Eastern Time on November 13, 2023.

Where can I access the live and archived webcast?

The live and archived webcast can be accessed on the Corporate Presentations page on the Cyclacel website at www.cyclacel.com.

Cyclacel Pharmaceuticals, Inc

NASDAQ:CYCC

CYCC Rankings

CYCC Latest News

CYCC Stock Data

2.00M
6.19M
4.82%
18.03%
3.1%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BERKELEY HEIGHTS